Clinical Trial Update: REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial update indicates a recruiting study comparing relugolix plus abiraterone acetate against leuprolide plus abiraterone acetate in patients with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)
• Leuprolide (Leuprolide acetate)
• Relugolix (Relugolix)

Snippet

Sponsor: Emory University | Conditions: Recurrent Prostate Carcinoma, Stage III Prostate Cancer AJCC v8 | Phase 3 | Status: RECRUITING